Connect
MJA
MJA

Pharmaceutical preparations

Matters arising

Possible genetic predisposition to cardiac effects

Hari Manev and Radmila M Manev

Med J Aust 2005; 182 (4): 198

Matters arising

Paracetamol should be first-line therapy in osteoarthritis

Richard O Day and Garry G Graham

Med J Aust 2005; 182 (4): 198-199

Public health

Mefloquine and doxycycline malaria prophylaxis in Australian soldiers in East Timor

Scott J Kitchener, Peter E Nasveld, Robin M Gregory and Michael D Edstein

Med J Aust 2005; 182 (4): 168-171 Free

Matters arising

Cardiovascular safety of rofecoxib (Vioxx): lessons learned and unanswered questions

Paul Langton, Graeme Hankey and John Eikelboom

Med J Aust 2005; 182 (4): 199

New Drugs, Old Drugs

Artemisinin-based combination therapies for uncomplicated malaria

Timothy M E Davis, Harin A Karunajeewa and Kenneth F Ilett

Med J Aust 2005; 182 (4): 181-185 Free

Notable cases

Myasthenia gravis and a rare complication of chemotherapy

Christina V T Ng

Med J Aust 2005; 182 (3): 120 Free

Lessons from practice

Bilateral acute angle closure caused by supraciliary effusions associated with venlafaxine intake

Maria Hannah Pia de Guzman, Sureka Thiagalingam, Poh Yan Ong and Ivan Goldberg

Med J Aust 2005; 182 (3): 121-123 Free

Notable cases

A syndromic rash in patients attending methadone clinics in New South Wales

Jon N Currie, Jimmy Chien, Lisa Snell, Margaret Cluff, Karen Scrivener, Lucinda Wallman and Elizabeth M Benson

Med J Aust 2005; 182 (2): 73-75 Free

Notable cases

A case of desquamating rash associated with methadone use

Natalie Kordjian, Annabelle D Donaldson, Steven A Krilis and Dedee F Murrell

Med J Aust 2005; 182 (2): 76-77 Free

Correction

Correction: Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Haemostasis and Thrombosis

Ross I Baker, Paul B Coughlin, Hatem H Salem, Alex S Gallus, Paul L Harper and Erica M Wood

Med J Aust 2005; 182 (1): 48

Letters

Tramadol and new-onset seizures

Angelo Labate, Mark R Newton, Graeme M Vernon and Samuel F Berkovic

Med J Aust 2005; 182 (1): 42-43

Letters

Audit of prescribed nicotine replacement therapy to hospital inpatients who smoke

Barbara A Hawkshaw and Yeqin Zuo

Med J Aust 2005; 182 (1): 43-44

Letters

Subsidised access to TNF-α inhibitors: is the rationale for exclusion of rheumatoid-factor-negative patients defensible?

Erica L Mann

Med J Aust 2005; 182 (1): 47-48

Letters

Drugs, sport and the Olympics 2000-2004

Anthony P Millar

Med J Aust 2004; 181 (10): 584

Research

Effectiveness and side effects of thiazolidinediones for type 2 diabetes: real-life experience from a tertiary hospital

Zanariah Hussein, John M Wentworth, Alison J Nankervis, Joseph Proietto and Peter G Colman

Med J Aust 2004; 181 (10): 536-539 Free

For debate

The dearth of new antibiotic development: why we should be worried and what we can do about it

Patrick G P Charles and M Lindsay Grayson

Med J Aust 2004; 181 (10): 549-553 Free

Letters

Critical shortage of injectable thiamine in Australia

Simon Spedding and Matt D Gaughwin

Med J Aust 2004; 181 (10): 577-578

Position statement

Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis

Ross I Baker, Paul B Coughlin, Hatem H Salem, Alex S Gallus, Paul L Harper and Erica M Wood

Med J Aust 2004; 181 (9): 492-497 Free

Obituaries

George Michael Eckert PhC, MB BS(Hons), MSc, PhD, MD

Allan J McLean, Lisa L Demos and Constantine G Berbatis

Med J Aust 2004; 181 (9): 503 Free

Editorials

Testosterone prescribing in Australia

Bronwyn GA Stuckey

Med J Aust 2004; 181 (8): 412-413

Research

Trends and regional differences in testosterone prescribing in Australia, 1991–2001

David J Handelsman

Med J Aust 2004; 181 (8): 419-422 Free

New Drugs, Old Drugs

The direct thrombin inhibitor melagatran/ximelagatran

Timothy A Brighton

Med J Aust 2004; 181 (8): 432-437 Free

Letters

Subsidised access to TNFα inhibitors: is the rationale for exclusion of rheumatoid-factor-negative patients defensible?

Christine Y Lu, Kenneth M Williams, Lyn March, James V Bertouch and Richard O Day

Med J Aust 2004; 181 (8): 457-458

Letters

Subsidised access to TNFα inhibitors: is the rationale for exclusion of rheumatoid-factor-negative patients defensible?

Lloyd N Sansom

Med J Aust 2004; 181 (8): 457-458

Letters

Preventing intrathecal administration of vincristine

Peter J Gilbar and Christine V Carrington

Med J Aust 2004; 181 (8): 464